Whereas very low-rely MBL rarely progresses to CLL, substantial-depend MBL progresses to CLL requiring therapy at a price of 1% to two% per year. High-depend MBL is distinguished from Rai 0 CLL depending on if the B-mobile depend is over or under five × 109/L. While people today with both high